This report contains market size and forecasts of IBS-C Drugs in global, including the following market information:
Global IBS-C Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global IBS-C Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five IBS-C Drugs companies in 2021 (%)
The global IBS-C Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IBS-C Drugs include Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc and Synthetic Biologics, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS-C Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IBS-C Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
Global IBS-C Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global IBS-C Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IBS-C Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies IBS-C Drugs revenues share in global market, 2021 (%)
Key companies IBS-C Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies IBS-C Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd